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Abstract
Background:  The study of microRNAs (miRNAs) is attracting great considerations. Recent
studies revealed that miRNAs play as important regulators of gene expression and some even as
cancer players or inhibitors. Many studies try to discover new miRNAs and reveal the miRNA
expression profile in cancer using a SAGE-based total RNA clone method. However, the data
processing of this method is labor-intensive with several different biological databases and more
than ten data processing steps involved.
Results:  With miRAS, miRNAs and possible miRNA candidates contained in the submitted
sequencing data were obtained together with their expression profile. The functions of known and
predicted miRNAs were then analyzed by miRNA target prediction followed by target gene
annotations. Finally, to extract the biological significance of the miRNAs in the samples, further
annotations of the known miRNA and target genes were performed by collecting the public
expression datasets of miRNA and target genes in normal and cancer tissues.
Conclusion: We introduce a web-based analysis platform called miRNA Analysis System (miRAS),
for processing and analyzing of the sequence data obtained from the total RNA clone method. The
system was built on generalizing the study of a liver cancer cell line total RNA sequencing project.
miRAS is freely available on the web.
Background
MicroRNAs (miRNAs) are a class of small non-coding
RNAs that regulate gene expression by binding to their tar-
get mRNAs and triggering either protein translation repres-
sion or RNA degradation [1]. Recent studies show that
some miRNAs are located at fragile sites and genomic
regions involved in cancers [2]. The aberrant expression of
miRNA genes could lead to human disease, including can-
cer [3-6], and are regarded as potential biomarkers for can-
cer diagnosis [7,8]. The roles miRNAs play have been
demonstrated in a few cancer types including breast cancer
[9], lung cancer [10] and chronic lymphocytic leukemia
[2,11,12], while the roles of miRNA in other cancers
remain largely unknown.
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There are several approaches of studying miRNAs and their
expression profiles, including Northern blotting and real-
time PCR assay. There are also available high-throughput
methods such as oligonucleotide miRNA microarray anal-
ysis [13-15], bead-based flow-cytometric technique [8],
and SAGE-based miRAGE [16]. miRNA microarray analysis
is a commonly used high-throughput technique for the
assessment of previously discovered miRNAs. With the
SAGE-based technique, such as miRAGE, the expression
profiles of known miRNAs could be retrieved together with
the unknown ones which are possible miRNA candidates.
For gene expression SAGE studies [17,18], there exist sev-
eral well developed methods for data analysis together with
web services provided, such as SAGEmap [19] and SAGE
Genie [20]. For miRNA-related SAGE, however, the data
analysis is much more complicated. The extracted tags have
to be compared with various RNA databases in addition to
mRNA sequences. The tags also need to be mapped to the
human genome and to be analyzed for precursors with
thermodynamically stable hairpin structures. This is a very
troublesome process and current users have to refer to sev-
eral different databases to retrieve related biologically sig-
nificant data [16]. To aid the processing and data analysis
of this method, we constructed a web-based system, named
miRNA Analysis System (miRAS). The expression profile of
known miRNAs in submitted sequences were returned and
compared with public dataset using Fisher's exact test. Pub-
lic available datasets of known miRNAs expression in liver
were collected for the annotation of miRNA expression in
liver. Several public available gene expression datasets were
included to reveal differentially expressed genes in liver
cancer and normal liver tissues. The differentially expressed
miRNAs and genes are highlighted and the relationship
between miRNAs and genes is shown according to miRNA
target prediction.
Results and Discussion
Users could upload the raw sequencing data and specify the
sequencing parameters through the web interface. The
known miRNAs and possible miRNA candidates will be
analyzed together with their expression profiles. The target
genes predicted by miRNA target prediction software are
provided together with the annotation information. To
demonstrate the biological significance of the retrieved
miRNAs, the profiles of public datasets of known miRNAs
and target genes were collected and included in the anno-
tation.
The miRAS system provides an easy and friendly way for
scientists to analyze and process raw miRNA sequence data
to obtain new miRNA candidates. It also provides tools for
the annotations of the predicted miRNAs.
Conclusion
In this work, we established a web-based analysis platform
for miRNAs, called miRAS [21], to analyze the miRNA
expression in specific tissue and to predict and study the
possible miRNA candidates. The differentially expressed
miRNAs that target differentially expressed genes are
retrieved together with miRNA and target gene annotation,
to uncover the biological significance. Currently it supports
liver cancer genes, while in the future, the analysis platform
is planned to be expanded to support other cancers and to
integrate all public available expression data of the miRNAs
and genes in cancer and normal tissues.
Methods
The work flow of miRAS is diagrammed in Figure 1. Details
of the major steps  of the system are described in the follow-
ing sections.
Preliminary processing of sequence data
Multiple sequence data of RNA sequencing in multi-fasta
format could be uploaded for analysis directly. The raw
sequencing data in trace file format could be compressed in
tar, tar.gz, zip, or rar format, and uploaded.
If the trace data of total RNA sequencing result is selected,
the sequence and quality of the sequence data will be
checked by PHRED [22,23], which reads DNA sequence
trace data, calls bases, assigns quality values to the bases,
and writes the base calls and quality values to output files.
Sequences with low quality base call values, to be removed,
are detected by PHRED with default parameters, which
explore modified Mott trimming algorithm, an error prob-
ability cutoff value of 0.05 and a minimum segment length
of 20 bases. The produced high-quality reads are then com-
pared to the vector sequence consensus using the cross-
match program, the mostly used software of finding vector
regions on sequencing reads. Parameters of -minmatch 12
-minscore 20 are used as default, while users could also
apply their own parameters through the web interface. A
standard vector database provided by PHRAP package is
used as default and it can also be specified by the users. The
detected vector sequences contained in the sequence reads
will be removed. The adapter sequences contained in the
miRNA clone sequences are checked and removed simi-
larly, using the cross-match program with parameters (-
minmatch 8 -minscore 14) for combined adaptors and (-
minmatch 8 -minscore 8) for single adapters.
Extraction of known miRNAs and primary new candidate 
miRNAs
After removal of the adapter sequences, redundant RNA
segments are removed and the copy numbers of each seg-
ment are recorded. The resulting short RNA segments are
searched against a known human miRNA dataset (miRNA
Registry Release 9.1) [24,25] to retrieve known miRNAs.BMC Bioinformatics 2007, 8:285 http://www.biomedcentral.com/1471-2105/8/285
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The expressions of the known miRNAs in given tissues are
compared with public expression data to obtain differen-
tially expressed or tissue specifically expressed miRNAs.
Other non-coding RNA (ncRNA) are identified in a similar
way, by searching against a ncRNA database, which was
built by combining several public RNA databases, includ-
ing rRNA database from Ribosomal Database Project
(RDP) [26], ncRNA database from NONCODE [27] and
Regulatory noncoding RNAs database [28]. 1 nt miss
match is allowed in retrieving the blast output for the toler-
ance of mistake in DNA sequencing. Those not included in
the known miRNAs or other ncRNA databases are treated
as primary miRNA candidates.
Pre-miRNA retrieval and secondary miRNA candidates 
screening
The primary miRNA candidates identified from the previ-
ous step are aligned to the human genome. For each
aligned segment, the 99 nucleotides upstream to the align-
ment position on the genome, the sequence of the primary
candidate miRNA itself, and the 99 nucleotides down-
stream to it on the genome are concatenated and used as a
possible precursor sequence of the primary candidate. The
secondary structures of the precursor sequences are pre-
dicted with the mfold program [29] and RNAfold [30], and
checked with two criteria of miRNA precursors: 1) whether
the candidate precursor sequence has a characteristic hair-
pin secondary structure and 2) whether a single miRNA
molecule accumulates one arm of a hairpin precursor mol-
ecule [31]. Support vector machine (SVM) [32] is applied
to classify real vs. pseudo pre-miRNAs.
miRNA target prediction and function annotation
The 3' untranslated region (3' UTR) of known human genes
were retrieved from UCSC website. The most commonly
used miRNA target scan program for mammalian,
miRanda program [33], is used to predict the target genes
of the known miRNAs and miRNA candidates. To demon-
strate the biological significance of the target genes, several
datasets of microarray were studied to obtain differentially
expressed genes in normal and cancer tissues. The results
are shown together with the target gene annotations.
The expression profiles of the miRNAs are included in the
analyses to reveal the regulatory roles of the miRNAs. The
expression data of normal liver tissue miRNAs were
obtained from the RNA Project at Rockefeller [34]. The
expression of known miRNAs retrieved from users' clone
data are compared with that in normal liver using Fisher's
exact test to find differentially expressed miRNAs in users'
RNA clone and normal liver tissues.
To further view expression profiles of known miRNAs in
liver, public available expression datasets of miRNA in liver
were collected and processed. Different types of miRNA
expression data, such as SAGE, microarray and bead-base
array, were processed with different methods. For SAGE
based data, Tags per million (TPM) of a miRNA, regarded
as the expression level of this miRNA, is calculated and
shown in our web display. For bead-base array and micro-
array, on the other hand, the log ratio value (M value) is
normally directly provided by the data source. In some
cases, several M values were provided and the average val-
ues were computed in our study. The M value represents
overexpression or underexpression level of each miRNA,
and is shown in the web interface.
The expression data of the target genes of known miRNAs
were also provided. The microarray datasets were processed
with the siggenes module of the R package from Biocon-
ductor [35] which implements the algorithm of Signifi-
cance Analysis of Microarrays (SAM) proposed by Tusher et
al [36], using a modified t statistics by scoring each gene on
the basis of change in gene expression relative to the stand-
ard deviation of repeated measurements. For SAGE data-
Table 2: Liver gene expression datasets in miRAS
Dataset Type Dataset Name Tissue Description
Microarray:
Hep3B vs Universal_control* Hepatoma cell line
SNU_387 vs Universal_control* Hepatoma cell line
HepG2 vs Universal_control* Hepatoma cell line
PLC_PRF_5 vs Universal_control* Hepatoma cell line
SNU_182 vs Universal_control* Hepatoma cell line
SNU_354 vs Universal_control* Hepatoma cell line
SNU_368 vs Universal_control* Hepatoma cell line
SNU_449 vs Universal_control* Hepatoma cell line
SNU_475 vs Universal_control* Hepatoma cell line
SAGE:
SAGE_Liver_cholangiocarcinoma_B_K1** Liver
SAGE_Liver_cholangiocarcinoma_B_K2D** Liver
SAGE_Liver_cholangiocarcinoma_CL_K3** Liver cell line
SAGE_Liver_cholangiocarcinoma_CL_K4** Liver cell line
SAGE_Liver_normal_B_1** Normal bulk liver
* Datasets from GEO [43], GEO accession GSM81024- GSM81059
** Datasets from SAGE Genie [44] of CGAP, names are for library.
Table 1: Liver miRNA expression datasets in miRAS
Provider Dataset Type Tissue Description
Rockefeller Univ.* SAGE Mouse liver tissue
Shingara, J., et al. ** Microarray Mouse liver tissue
Farh, K.K., et al.** Microarray Mouse liver tissue
Thomson, J.M., et al.*** Microarray Mouse liver tissue
Lu, J., et al.*** Bead-base array Human normal liver
Wienholds, E., et al.*** Microarray Zebrafish tissues
* Datasets from the Rockefeller University RNA project [34].
** Datasets available from supplements of article, references [41] and 
[42], respectively.
*** Datasets available from Gene Expression Omnibus (GEO) [43] 
with accession number of GSE1635, GSE2564, and GSE2628, 
respectively.BMC Bioinformatics 2007, 8:285 http://www.biomedcentral.com/1471-2105/8/285
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Work flow of miRAS Figure 1
Work flow of miRAS.BMC Bioinformatics 2007, 8:285 http://www.biomedcentral.com/1471-2105/8/285
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sets, SAGE tags were mapped to known genes with the data
provided by NCBI ftp site [37]. The differential expression
between cancerous cell and normal cell was analyzed using
Fisher's exact test [38-40], implemented with the sagenhaft
module of R. For both types, M values were computed to
represent the differential expression of the genes for cancer-
ous vs. normal tissues.
The expression datasets of known miRNAs and their target
genes included in miRAS are listed in Table 1 and Table 2.
Result retrieval
Through the result view page, the base-calling result,
known mRNAs and other ncRNAs, possible miRNA candi-
dates together with the secondary structures, target predic-
tion result and their expressions in known datasets are
returned. For users to view result in more convenience, dif-
ferent data formats are provided, such as raw data file, text
file and Microsoft excel.
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